Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sage Therapeutics IncfiledCriticalSage Therapeutics Inc
Publication of AR122400A1publicationCriticalpatent/AR122400A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se proporcionan en el presente documento métodos para tratar un síntoma de una afección respiratoria o una enfermedad asociada a un coronavirus, de un sujeto, que comprende administración al sujeto una cantidad eficaz de un agente seleccionado del grupo que consiste en el compuesto 1 y el compuesto 2, o una sal farmacéuticamente aceptable de este.Provided herein are methods of treating a symptom of a coronavirus-associated respiratory condition or illness of a subject, comprising administering to the subject an effective amount of an agent selected from the group consisting of Compound 1 and Compound 2, or a pharmaceutically acceptable salt thereof.
ARP210100743A2020-03-252021-03-25
USE OF AGENTS FOR THE TREATMENT OF RESPIRATORY CONDITIONS
AR122400A1
(en)